Results 51 to 60 of about 16,868 (148)
The COVID-19 pandemic demonstrated that the current purely market-driven approaches to drug discovery and development alone are insufficient to drive equitable access to new therapies either in preparation for, or in response to, pandemics.
Ed J. Griffen, Pascale Boulet
doaj +1 more source
Embracing novel thinking to safeguard against airborne pathogens in indoor spaces
H. van der Westhuizen +12 more
doaj +1 more source
Epidemiological and Molecular Surveillance of Multiresistant Citrobacter freundii Complex in a Tertiary Care Hospital: A Retrospective Cohort Study. [PDF]
Fonton P +6 more
europepmc +1 more source
Kenya's integrated program for cervical and breast cancer's early detection. [PDF]
Sangara D +4 more
europepmc +1 more source
The Access to Oncology Medicines Coalition: Enhanced in-Country Coordination for Sustainable Access
Diogo de Sousa Neves,1,2 Shalini Jayasekar Zürn,2 Thuy Khuc-Bilon,2 Melissa Rendler-Garcia,2 Yehoda M Martei,3 Sumithra Krishnamurthy Reddiar2 1Independent Global Health Consultant, Paris, Ile-de-France, France; 2ATOM Coalition Secretariat, Union for ...
de Sousa Neves D +5 more
doaj
Hypoperfusion in early-phase amyloid PET as a predictor of cognitive decline in Alzheimer's disease. [PDF]
Škorvagová A +11 more
europepmc +1 more source
Strengthening operational research to complement Global Fund grants for HIV, TB and malaria in Sierra Leone. [PDF]
Kenneh S +4 more
europepmc +1 more source

